LncRNA ZFAS1 serves as a prognostic biomarker to predict the survival of patients with ovarian cancer-Reference-Cited by-同舟云学术

LncRNA ZFAS1 serves as a prognostic biomarker to predict the survival of patients with ovarian cancer

Published:2019-10-25 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Han Shuang¹,Li De‑Zhan²,Xiao Mei‑Fang³

Affiliation:

1. Department of Gynaecology, Jingzhou Central Hospital, The Second Clinical Medical College, Yangtze University, Jingzhou, Hubei 434020, P.R. China

2. Department of Anesthesiology, Jingzhou Central Hospital, The Second Clinical Medical College, Yangtze University, Jingzhou, Hubei 434020, P.R. China

3. Department of Clinical Laboratory, Center for Laboratory Medicine, Hainan Women and Children's Medical Center, Haikou, Hainan 570206, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Expression Analysis of Long Non-coding RNAs Related to Wnt/β-Catenin Signaling in Pancreatic Cancer Patients;Biochemical Genetics;2024-04-09

2. Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis;International Journal of Molecular Sciences;2023-06-28

3. Single cell RNA-seq analysis identifies a noncoding RNA mediating resistance to sorafenib treatment in HCC;Molecular Cancer;2022-01-03

4. LncRNA ZFAS1: Role in tumorigenesis and other diseases;Biomedicine & Pharmacotherapy;2021-10

5. lncRNA ZFAS1 promotes the ox‑LDL induced proliferation, invasion and migration of vascular smooth muscle cells;Experimental and Therapeutic Medicine;2021-06-04